Expression of Robo protein in bladder cancer tissues and its effect on the growth of cancer cells by blocking Robo protein.

This study aimed to detect the expression of Slit signaling protein ligand Robo protein in human bladder cancer and para-carcinoma tissue, and observe the tumor cell survival and growth by inoculating the bladder cancer cells with the blocked signaling protein into the subcutaneous tissue of nude mice. The expression of Robo protein was detected in T24 cells in human bladder uroepithelium carcinoma and cultivated human bladder uroepithelium carcinoma confirmed by pathological diagnosis. The cultivated T24 cells were coated by the protein antibody and human bladder uroepithelium carcinoma T24 tumor-bearing mice model was established. The tumor cell survival and growth were observed in the antibody coating group and non-coating group. The tumor body size was measured. The immunohistochemical detection showed that Robo protein isoforms Robo1 and Robo 4 were expressed in T24 cells of cancer tissues, paracarcinoma tissues and cultured human uroepithelium carcinoma. The expression of Robo1 was significantly higher than that of Robo4 (P<0.05). The cancer cells could be detected in nodular tumor of mice in each group. The volume of the tumor-bearing mice in the nodular tumor of the non-coating group was larger than that of anti-Robol antibody coating group and the difference was statistically significant (P<0.01). There was no significant difference in tumor volume between anti-Robo4 antibody coating group and non-coating group (P>0.05); The difference was statistically significant compared with the anti-Robo1 antibody coating group (P<0.01). In conclusion, Robo protein isoforms Robo1 and Robo4 were expressed in human bladder cancer T24 cells. To block Robo4 signal protein had little effect on the survival and growth of the transplantation tumor and to block Robo1 signal protein would seriously affect the survival and growth of the transplantation tumor, suggesting that Robo1 might play an important role in the growth and metastasis of bladder cancer, and might become a new target for the treatment of human bladder cancer and drug research.

[1]  A. Harris,et al.  Bladder Cancer Accounts for Approximately 8% and 6% of All New , 2022 .

[2]  Cai-Feng Dai,et al.  Expression and roles of Slit/Robo in human ovarian cancer , 2011, Histochemistry and Cell Biology.

[3]  W. Andrews,et al.  Slit–Robo interactions during cortical development , 2007, Journal of anatomy.

[4]  C. Nüsslein-Volhard,et al.  Mutations affecting the pattern of the larval cuticle inDrosophila melanogaster , 2004, Wilhelm Roux's archives of developmental biology.

[5]  J. Panse,et al.  Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC). , 2005, Lung cancer.

[6]  Dean Y. Li,et al.  Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm , 2011, Current opinion in hematology.

[7]  W. C. Duncan,et al.  The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. , 2010, Reproduction.

[8]  Yang Di,et al.  The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. , 2013, Oncology reports.

[9]  T. Todenhöfer,et al.  Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer , 2015, BMC Cancer.

[10]  C. Nüsslein-Volhard,et al.  Mutations affecting the pattern of the larval cuticle inDrosophila melanogaster , 1984, Wilhelm Roux's archives of developmental biology.

[11]  L. Hinck,et al.  A roundabout way to cancer. , 2012, Advances in cancer research.

[12]  J. Rothberg,et al.  slit: an extracellular protein necessary for development of midline glia and commissural axon pathways contains both EGF and LRR domains. , 1990, Genes & development.